1. Home
  2. SCLX vs KLXE Comparison

SCLX vs KLXE Comparison

Compare SCLX & KLXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLX
  • KLXE
  • Stock Information
  • Founded
  • SCLX 2011
  • KLXE 2018
  • Country
  • SCLX United States
  • KLXE United States
  • Employees
  • SCLX N/A
  • KLXE 1919
  • Industry
  • SCLX Biotechnology: Pharmaceutical Preparations
  • KLXE Oilfield Services/Equipment
  • Sector
  • SCLX Health Care
  • KLXE Energy
  • Exchange
  • SCLX Nasdaq
  • KLXE Nasdaq
  • Market Cap
  • SCLX 81.7M
  • KLXE 79.4M
  • IPO Year
  • SCLX N/A
  • KLXE N/A
  • Fundamental
  • Price
  • SCLX $0.48
  • KLXE $4.90
  • Analyst Decision
  • SCLX Strong Buy
  • KLXE Hold
  • Analyst Count
  • SCLX 3
  • KLXE 1
  • Target Price
  • SCLX $11.33
  • KLXE $4.50
  • AVG Volume (30 Days)
  • SCLX 184.3K
  • KLXE 104.4K
  • Earning Date
  • SCLX 12-24-2024
  • KLXE 10-31-2024
  • Dividend Yield
  • SCLX N/A
  • KLXE N/A
  • EPS Growth
  • SCLX N/A
  • KLXE N/A
  • EPS
  • SCLX N/A
  • KLXE N/A
  • Revenue
  • SCLX $50,833,000.00
  • KLXE $738,000,000.00
  • Revenue This Year
  • SCLX $32.77
  • KLXE N/A
  • Revenue Next Year
  • SCLX $50.71
  • KLXE $4.79
  • P/E Ratio
  • SCLX N/A
  • KLXE N/A
  • Revenue Growth
  • SCLX 9.41
  • KLXE N/A
  • 52 Week Low
  • SCLX $0.46
  • KLXE $4.18
  • 52 Week High
  • SCLX $2.63
  • KLXE $12.13
  • Technical
  • Relative Strength Index (RSI)
  • SCLX 33.34
  • KLXE 39.30
  • Support Level
  • SCLX $0.48
  • KLXE $4.90
  • Resistance Level
  • SCLX $0.54
  • KLXE $5.34
  • Average True Range (ATR)
  • SCLX 0.06
  • KLXE 0.37
  • MACD
  • SCLX -0.00
  • KLXE -0.13
  • Stochastic Oscillator
  • SCLX 4.53
  • KLXE 22.45

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

Share on Social Networks: